About Michael Riley
Michael Riley is an executive officer and director at Bond Biosciences.
Michael Riley first appears on SEC filings in 2020.
Experience
This experience comes from SEC filings. The years are when the filings name Michael Riley in the role, so the role may have started earlier or lasted longer.
Bond Biosciences, Inc.
Executive officer and director
2020 – 2026 · Parkville, MO
Develops oral drugs for people with diseases caused by excess ions.
Key Colleagues at Startups
The people Michael Riley works with at each company, as listed on that company's latest Form D.
Bond Biosciences, Inc. · Form D/A, Oct 5, 2026
